Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: REALISE study
Safety of Viaskin Peanut Patch Therapy Improved Over 3-Year Study
Dave Bloom
-
2021/11/11
Reactions decreased over study duration.
DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut...
News Wire ~ 3rd Party Press Release
-
2019/08/08
This submission addresses the additional data needed on manufacturing procedures and quality controls which were communicated by the FDA in December.
DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy
News Wire ~ 3rd Party Press Release
-
2018/10/23
"This submission represents a significant step forward for those families living with peanut allergy."
Positive Safety Results Reported for Viaskin Peanut Phase III Trial
Dave Bloom
-
2017/11/20
The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.
Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...
Dave Bloom
-
2017/03/22
The study received higher-than-expected patient demand.